Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
about
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsCase-based study: from prediabetes to complications--opportunities for preventionLow-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-upA low-carbohydrate, ketogenic diet to treat type 2 diabetes.The DiGEM trial protocol--a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factorsComparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinationsRole of insulin in the type 2 diabetes therapy: past, present and futureManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyGlycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adultsIntensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesReduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminCardiovascular outcomes in trials of oral diabetes medications: a systematic reviewAn instrumental variable analysis of the impact of practice guidelines on improving quality of care and diabetes-related outcomes in the elderly Medicare populationInsulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusBlood pressure control for diabetic retinopathyIntensive versus conventional glycaemic control for treating diabetic foot ulcersSulphonylurea monotherapy for patients with type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTheory-based behavioural interventions for prediabetic state and people with diabetes mellitusPramlintide for diabetes mellitusMetformin monotherapy for type 2 diabetes mellitusContinuous glucose monitoring systems for type 2 diabetes mellitusAnti-vascular endothelial growth factor for proliferative diabetic retinopathyTreatment of periodontal disease for glycaemic control in people with diabetes mellitusIntensive versus conventional glycaemic control for treating diabetic foot ulcersSulphonylurea monotherapy for patients with type 2 diabetes mellitusGlucose targets for preventing diabetic kidney disease and its progressionBeta-blockers for hypertensionBromocriptine for type 2 diabetes mellitusAntihypertensive agents for preventing diabetic kidney diseaseTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusEnhanced glucose control for preventing and treating diabetic neuropathyBeta-blockers for hypertensionNon-incretin insulin secretagogues for patients with type 2 diabetes mellitusComputer-based diabetes self-management interventions for adults with type 2 diabetes mellitusTreatment of periodontal disease for glycaemic control in people with diabetesContinuous glucose monitoring systems for type 2 diabetes mellitus
P2860
Q21144611-929A7A40-AD3F-4AF0-809A-A13B43DF8BBDQ21144738-7902F722-088D-4F4C-BFB2-54555D37256CQ21245076-BCE43DD2-5E34-4AFE-80BD-7E6BB301FFD5Q21245078-1734621F-DC4E-42DE-A5D8-63648DFAA0ACQ21261909-EB552222-5A33-446B-8E4A-2DBF9C7E5431Q21563399-38174524-B8FB-4A4D-BBEE-355B3586625BQ22241134-10D348AE-9A1D-446C-B338-45C69AB6C53AQ22241148-78E6452E-0B14-49CC-B00B-0A8CF9817F15Q22241288-191A0655-5C02-4471-955C-97F8618BF030Q22241786-AE48663F-6B9F-4583-8C35-0EAA25E07392Q22242096-D318C1CE-D77A-4CE6-8C91-D124DEA34F0FQ22250879-05494CB4-A397-49D0-A7DA-5237A47DFE7EQ22250887-567DD3FD-373C-4D97-8684-754E5161B32CQ22250892-D723A80B-6905-4F6B-A6C5-9239F63539FEQ22253058-9B156821-BFD1-4E45-B6B8-15D3E0A38E87Q23922089-C14F3510-049D-4943-BCD1-6792AC11C268Q24185970-24BBDE9A-EE30-48ED-A5CF-A1D098C4FCEEQ24186434-A2F03E85-BE6B-41F3-8591-106BD900A686Q24186487-BD142FEC-FDE1-4A92-AC7A-E9E2DCFF9DE1Q24186660-CC0A9A41-40FB-44A2-BA98-B3492E14B23FQ24186667-1A4BB1F5-CA8A-4E01-8186-2211BE6E04C2Q24186851-3BB4A39C-97AE-424E-A54C-C5DD94AAE811Q24186857-D252A712-5B47-4FE7-B963-0213A92F5219Q24187392-203490D6-4C37-4E44-8C8C-2F9A58CE32EBQ24187648-7797A039-A0AF-4EC1-BB52-F07FEBA1B895Q24187858-EB69C284-4197-4B35-9AE6-FA16BA8B6F28Q24187907-AE86CDA0-DCD1-4EB3-8579-F11EBFB13BE0Q24197832-3A3BA702-E990-4A0D-8429-47FD42BE927CQ24197884-34DE70A6-7D75-4DC6-A1EB-D73E5ED375EEQ24198925-486F80B3-3252-4775-AD1E-7DDD00AB9EC2Q24201511-8DB89067-91B5-46E8-87EB-42117B6DD299Q24201924-64CF3FC8-B69C-4F7A-BBB6-7BBD1B34C959Q24202090-CA0C89F7-4D5C-4CB5-811D-3E6BE420BB33Q24202505-50B9E02B-9BFF-497D-95A8-A0EF0CB186F8Q24202790-52BD7570-93DD-4179-9A62-92BF64E2C66BQ24202812-BCE628B8-625C-4121-9151-4245BD57F07FQ24234574-1D9A6733-BB74-4FF8-801F-3F3930FDD858Q24234984-5D9A262D-864E-4B66-B088-653E28E008FDQ24235332-04FE7DF2-0292-40C2-A687-CFABAF336D25Q24235570-1C536402-D66A-4C1E-BD26-9F7F121338CE
P2860
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@ast
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@en
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@nl
type
label
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@ast
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@en
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@nl
prefLabel
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@ast
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@en
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@nl
P921
P3181
P1433
P1476
Intensive blood-glucose contro ...... e Diabetes Study (UKPDS) Group
@en
P304
P3181
P356
10.1016/S0140-6736(98)07019-6
P407
P577
1998-09-12T00:00:00Z